[Skip to Content]
[Skip to Content Landing]
Article
August 1970

Splenectomy for Hematologic Disorders

Author Affiliations

Rochester, NY
From the departments of surgery (Drs. Schwartz, Bernard, and Adams) and medicine (Dr. Bauman), University of Rochester School of Medicine and Dentistry, Rochester, NY.

Arch Surg. 1970;101(2):338-347. doi:10.1001/archsurg.1970.01340260242036
Abstract

The results of splenectomy for hematologic disorders in 200 patients have been evaluated. Anticipated good results were achieved in all patients with hereditary spherocytosis and over 80% of patients with idiopathic thrombocytopenic purpura. A hematologic improvement in patients with thrombotic thrombocytopenic purpura, thalassemia, myeloid metaplasia, and malignant hemopathy occurred in a significant percentage of cases. The overall in-hospital mortality was 7% but was totally related to the primary disease process. It was concluded that the results justify broadening the indications for splenectomy in patients with hematologic disorders.

×